The plaintiffs in the $2.35 million award from last week, Douglas Muhlbauer and related entities, sued Stifel Nicolaus last ...

In a report released today, Stephen Willey from Stifel Nicolaus maintained a Hold rating on Bolt Biotherapeutics (BOLT – Research Report), with a price target of $1.50. The company’s shares closed ...

Stifel has downgraded Tempus AI (NASDAQ:TEM) to hold from buy, citing valuation and uncertainty about core growth in 2025.

A lawyer in the case says his legal team was able to present text messages showing a Stifel wealth manager had been touting complex structured notes as low-risk investments.

Stifel analyst Stephen Gengaro discusses how oil & gas companies may have to balance President-elect Trump's promise to boost ...

The stock market is "entering Crazy Town" as valuations creep toward generational highs, Stifel's chief equity strategist ...

U.S. inflation remains elevated based on the October CPI report released on Wednesday, complicating the outlook for the Federal Reserve's policy path, according to economists at Stifel, Nicolaus & Co.

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

Investment bank B. Riley Financial said on Friday it had agreed to sell a portion its traditional wealth management business ...

Cerus Corporation (Nasdaq: CERS) announced management participation in two upcoming investor conferences. Management plans to participate in the Stife ...

The Haskins Foundation announced Tuesday that Minnesota junior Isabella McCauley (Inver Grove, Heights, Minn.) was one of 25 ...

AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full ...